How food affects drug levels in healthy people
Part of Hormones & metabolism clinical trials.
This trial studies how food changes the way a drug moves through your body. Healthy volunteers take the medicine once with food and once without, to see if eating affects the drug levels and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 to 54 years old.
- Your BMI (body fat based on height and weight) is between 18 and 30.
- You have not taken certain drugs (like barbiturates) in the last 30 days that change how your body breaks down medicine.
- You agree to sign a consent form after understanding the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the body handles three diabetes medicines (dapagliflozin, linagliptin, and metformin) when taken with food. It is for healthy volunteers to check safety and drug levels.
This study looks at how different levels of kidney function affect the amount of a medication in the body. It may help doctors decide on the right dose for people with kidney problems.
This trial checks how eating food changes the way a new combination of three diabetes medicines (gemigliptin, dapagliflozin, metformin) is absorbed in healthy volunteers. It helps determine the best way to take the pill with or without food.
This trial tests how a new medication (chiglitazar combined with metformin extended-release) works in the body when taken with food and after multiple doses. Healthy volunteers are needed to help understand the drug's safety and how it is processed.
This trial tests the safety and how the body processes three common diabetes medications (dapagliflozin, linagliptin, and metformin) when taken together. Healthy volunteers are needed to help researchers understand how these drugs work in the body.
This trial tests whether a GLP-1 receptor agonist (a type of diabetes medication) can improve fat tissue health in people with chronic kidney disease who also have type 2 diabetes, cardiovascular disease, or obesity. It may help protect your kidneys and overall health.
Hear when a new Type 2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.